InsiderFlow

Joseph P Lyssikatos

ELVN

Joseph P Lyssikatos serves as officer: CHIEF SCIENTIFIC OFFICER at Enliven Therapeutics, Inc. (ELVN). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

39 trades

$15.91M

Net Position

Net Seller

$15.91M

Companies Traded

1

ELVN

Active Period

Sep 2023 – Feb 2026

39 total trades

Most Recent

Sell ELVN

Feb 10, 2026 · $145.2K

Joseph P Lyssikatos's Insider Trading at Enliven Therapeutics, Inc. (ELVN)

Buys

0 · $0.00

Sells

39 · $15.91M

Total Shares Bought

0

Total Shares Sold

672,347

ELVN Price Chart
Loading chart...
DateTypeValue
Feb 10, 2026 Sell$145.2K
Feb 6, 2026 Sell$145.2K
Jan 22, 2026 Sell$535.1K
Jan 20, 2026 Sell$535.1K
Jan 12, 2026 Sell$3.48M
Jan 8, 2026 Sell$3.48M
Dec 19, 2025 Sell$84.2K
Nov 19, 2025 Sell$279.2K
Oct 20, 2025 Sell$276.0K
Sep 26, 2025 Sell$81.0K
Sep 23, 2025 Sell$30.0K
Sep 19, 2025 Sell$135.7K
Aug 19, 2025 Sell$248.2K
Jul 21, 2025 Sell$278.6K
Jun 20, 2025 Sell$267.5K
Jun 3, 2025 Sell$150.2K
May 19, 2025 Sell$81.5K
May 1, 2025 Sell$150.4K
Apr 21, 2025 Sell$80.4K
Mar 19, 2025 Sell$257.6K
Oct 18, 2024 Sell$25.4K
Oct 8, 2024 Sell$1.44M
Oct 4, 2024 Sell$281.7K
Oct 1, 2024 Sell$14.5K
Aug 29, 2024 Sell$269.8K
Jul 31, 2024 Sell$85.4K
Jul 29, 2024 Sell$320.4K
Jul 1, 2024 Sell$274.7K
May 29, 2024 Sell$260.8K
Apr 29, 2024 Sell$215.0K
Apr 11, 2024 Sell$751.3K
Apr 1, 2024 Sell$223.1K
Feb 29, 2024 Sell$197.0K
Jan 29, 2024 Sell$190.3K
Dec 29, 2023 Sell$171.4K
Dec 21, 2023 Sell$85.8K
Dec 19, 2023 Sell$115.6K
Nov 3, 2023 Sell$111.8K
Sep 29, 2023 Sell$163.5K
Joseph P Lyssikatos Insider Trading Activity | Enliven Therapeutics, Inc. | InsiderFlow